Kalorama: Strong Growth in Women's Health Diagnostics Market
NEW YORK, Dec. 16, 2014 /PRNewswire/ -- The world markets for key women's health diagnostics, as forecast for 2013-2015, are showing strong growth, according to Kalorama Information. These include, among others, the markets for digital mammography, lab-based fertility testing and bone densitometry. Each of these key diagnostic areas is showing growth at greater than 4%, as high as 6%. The women's health arena, both therapeutics and diagnostics, has grown considerably as a specialty medical field. Once limited to obstetrics and gynecology, it now includes other fields, such as urology, maternal-fetal medicine, as well as autoimmune disease and cystic fibrosis. Kalorama's report, Diagnostic Markets for Women's Health, analyzes the current and potential world markets for key diagnostic tests targeted at women's health.
"The life expectancy of women is longer than for men and is climbing steadily due to advancements in medicine," said Joseph A. Constance, author of the healthcare market researcher's report. "Diagnostics are playing an ever-increasing role."
One example is the growth in the mammography systems marketplace, which will continue thanks in part to a growing use of digital mammography systems because of an increased public awareness of breast cancer, and the high efficiency and low dosage capability of advanced digital equipment. Fertility testing is another example of a rising women's health market. More than 7 million Americans, or approximately 12% of the population in their reproductive years, are infertile, according to the Centers for Disease Control and Prevention (CDC). As more couples address fertility issues and are presented with different treatment options, the market for fertility testing, namely lab-based immunoassays, should be strong, with growth in the 4% to 5% range annually worldwide.
Kalorama's report generally forecasts future market growth for diagnostic tests to 2018. Market segments covered include the U.S., Europe, China, Brazil, Japan and rest of world markets. Diagnostic Markets for Women's Health also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry.
The market for bone densitometry is another significant women's health market, as osteoporosis more commonly occurs in females. A woman's risk of hip fracture is equal to her risk of breast, uterine, and ovarian cancer combined. Osteoporosis is estimated to affect 200 million women worldwide: about 10% of women aged 60; 20% of women aged 70; 40% of women aged 80; more than 65% of women aged 90. The disease impacts approximately 75 million people in Europe, the U.S. and Japan. The alarming rise of osteoporosis has propelled the need for early detection of the disease, and has pushed demand for bone densitometers, driving this market up.
The report profiles several key companies, including large companies that have made names for themselves in the field, as well as smaller firms with market niches. These companies are involved in developing and marketing over the counter (OTC), point of care (POC) in vitro diagnostic (IVD) tests and screening systems. Some of the companies profiled include:
- GE Healthcare
- GenMark Diagnostics
- Hologic
- Immco Diagnostics
- Luminex
- Nova Biomedical
- Philips Healthcare
- Siemens Healthcare
- Somagen Diagnostics
Kalorama Information's report, Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing) provides market forecasts based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data are generated into multiple year forecasts for different product segments covered in the report. The report can be found at KI: http://www.kaloramainformation.com/Women-Health-Diagnostic-8487406/.
About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com
Logo - http://photos.prnewswire.com/prnh/20140801/132634
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kalorama-strong-growth-in-womens-health-diagnostics-market-300009955.html
SOURCE Kalorama Information
Share this article